{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:04:01Z","timestamp":1790773441931,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008501","name":"East Carolina University","doi-asserted-by":"publisher","award":["111104"],"award-info":[{"award-number":["111104"]}],"id":[{"id":"10.13039\/100008501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008501","name":"East Carolina University","doi-asserted-by":"publisher","award":["111110-668715-0000"],"award-info":[{"award-number":["111110-668715-0000"]}],"id":[{"id":"10.13039\/100008501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Biological Regulation"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jbior.2018.06.002","type":"journal-article","created":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T06:31:58Z","timestamp":1530167518000},"page":"16-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals"],"prefix":"10.1016","volume":"69","author":[{"given":"Stephen L.","family":"Abrams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kvin","family":"Lertpiriyapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li V.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-7260","authenticated-orcid":false,"given":"Alberto M.","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9801-7235","authenticated-orcid":false,"given":"Marco","family":"Falasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8478-6981","authenticated-orcid":false,"given":"Ramiro M.","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0812-4027","authenticated-orcid":false,"given":"Pedro L.","family":"Rosalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7971-7404","authenticated-orcid":false,"given":"Paolo","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Libra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Candido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Montalto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4923-7220","authenticated-orcid":false,"given":"Melchiorre","family":"Cervello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Steelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"McCubrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbior.2018.06.002_bib1","doi-asserted-by":"crossref","first-page":"76525","DOI":"10.18632\/oncotarget.20408","article-title":"Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells","volume":"8","author":"Abrams","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2018.06.002_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jbior.2017.11.007","article-title":"Molecular and cellular mechanisms of chemoresistance in pancreatic cancer","volume":"68","author":"Adamska","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jbior.2017.12.001","article-title":"Remodeling of Ca2+ signaling in cancer: regulation of inositol 1,4,5-trisphosphate receptors through oncogenes and tumor suppressors","volume":"68","author":"Ando","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib4","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archinternmed.2010.63","article-title":"Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan)","volume":"170","author":"Arslan","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jbior.2018.06.002_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1477-2574.2009.00109.x","article-title":"Proteasome inhibition enhances antitumour effects of gemcitabine in experimental pancreatic cancer","volume":"11","author":"Awasthi","year":"2009","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jbior.2018.06.002_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/jcb.23405","article-title":"The efficacy of a novel, dual PI3K\/mTOR inhibitor NVP-BEZ235 to enhance chemotherapy and antiangiogenic response in pancreatic cancer","volume":"113","author":"Awasthi","year":"2012","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jbior.2018.06.002_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12943-015-0468-0","article-title":"Dasatinib blocks transcriptional and promigratory responses to transforming growth factor-beta in pancreatic adenocarcinoma cells through inhibition of Smad signalling: implications for in vivo mode of action","volume":"14","author":"Bartscht","year":"2015","journal-title":"Mol. Canc."},{"key":"10.1016\/j.jbior.2018.06.002_bib8","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1158\/1078-0432.CCR-09-0227","article-title":"SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer","volume":"15","author":"Blackford","year":"2009","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.jbior.2018.06.002_bib9","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.4_suppl.358","article-title":"A phase II pilot trial of nivolumab (N) + albumin bound paclitaxel (AP) + paricalcitol (P) + cisplatin (C) + gemcitabine (G) (NAPPCG) in patients with previously untreated metastatic pancreatic ductal adenocarcinoma (PDAC)","volume":"36","author":"Borazanci","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbior.2018.06.002_bib10","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1093\/annonc\/mdu276","article-title":"Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium","volume":"25","author":"Bosetti","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbior.2018.06.002_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10637-010-9564-6","article-title":"Anti-leukemic activity of dasatinib in both p53(wild-type) and p53(mutated) B malignant cells","volume":"30","author":"Bosco","year":"2012","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.jbior.2018.06.002_bib12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","article-title":"When mutants gain new powers: news from the mutant p53 field","volume":"9","author":"Brosh","year":"2009","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.jbior.2018.06.002_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm0302-282","article-title":"Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound","volume":"8","author":"Bykov","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbior.2018.06.002_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jbior.2016.09.002","article-title":"Rab11 and phosphoinositides: a synergy of signal transducers in the control of vesicular trafficking","volume":"63","author":"Campa","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jbior.2018.02.002","article-title":"Metformin influences drug sensitivity in pancreatic cancer cells","volume":"68","author":"Candido","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib16","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/sj.bjc.6604995","article-title":"Activity of a novel, dual PI3-kinase\/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts","volume":"100","author":"Cao","year":"2009","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.jbior.2018.06.002_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jbior.2017.08.001","article-title":"Phosphatidate phosphatase regulates membrane phospholipid synthesis via phosphatidylserine synthase","volume":"67","author":"Carman","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jbior.2017.06.002","article-title":"Pivotal roles of glycogen synthase-3 in hepatocellular carcinoma","volume":"65","author":"Cervello","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib19","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.4161\/cc.22852","article-title":"p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3","volume":"11","author":"Chappell","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbior.2018.06.002_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jbior.2015.10.001","article-title":"Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cells","volume":"60","author":"Chappell","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2018.05.002","article-title":"Roles of p53, NF-\u03baB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines","author":"Chappell","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib22","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1101\/gad.10.19.2438","article-title":"p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells","volume":"10","author":"Chen","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbior.2018.06.002_bib23","first-page":"1221","article-title":"Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells","volume":"34","author":"Choi","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jbior.2018.06.002_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0014-5793(02)02292-5","article-title":"Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction","volume":"512","author":"Choudhuri","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jbior.2018.06.002_bib25","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.M410670200","article-title":"Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner","volume":"280","author":"Choudhuri","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbior.2018.06.002_bib26","first-page":"59","article-title":"Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines","volume":"17","author":"Chuang","year":"2017","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.jbior.2018.06.002_bib27","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbior.2018.06.002_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11912-012-0290-4","article-title":"The role of the FOLFIRINOX regimen for advanced pancreatic cancer","volume":"15","author":"Conroy","year":"2013","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jbior.2018.06.002_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.canlet.2016.03.017","article-title":"APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines","volume":"375","author":"Deben","year":"2016","journal-title":"Canc. Lett."},{"key":"10.1016\/j.jbior.2018.06.002_bib30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MPA.0b013e3181c15963","article-title":"Phenotype and genotype of pancreatic cancer cell lines","volume":"39","author":"Deer","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.jbior.2018.06.002_bib31","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1158\/0008-5472.CAN-16-2339","article-title":"Pancreatic cancer progression relies upon mutant p53-Induced oncogenic signaling mediated by NOP14","volume":"77","author":"Du","year":"2017","journal-title":"Canc. Res."},{"key":"10.1016\/j.jbior.2018.06.002_bib32","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.3748\/wjg.v10.i24.3583","article-title":"The effect of adenovirus expressing wild-type p53 on 5-fluorouracil chemosensitivity is related to p53 status in pancreatic cancer cell lines","volume":"10","author":"Eisold","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jbior.2018.06.002_bib33","doi-asserted-by":"crossref","first-page":"8763","DOI":"10.1073\/pnas.86.22.8763","article-title":"Wild-type p53 can inhibit oncogene-mediated focus formation","volume":"86","author":"Eliyahu","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jbior.2018.06.002_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9100140","article-title":"Targeting PDK1 for chemosensitization of cancer cells","volume":"9","author":"Emmanouilidi","year":"2017","journal-title":"Cancer (Basel)"},{"key":"10.1016\/j.jbior.2018.06.002_bib35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/annonc\/mdw607","article-title":"Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer","volume":"28","author":"Evans","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbior.2018.06.002_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.bjc.6605408","article-title":"A novel inhibitor of the PI3K\/Akt pathway based on the structure of inositol 1,3,4,5,6-pentakisphosphate","volume":"102","author":"Falasca","year":"2010","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.jbior.2018.06.002_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1634\/theoncologist.2012-0435","article-title":"FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience","volume":"18","author":"Faris","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.jbior.2018.06.002_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbamcr.2014.10.003","article-title":"Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine","volume":"1853","author":"Fiorini","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbior.2018.06.002_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jbior.2015.06.003","article-title":"Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells","volume":"59","author":"Fitzgerald","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02788373","article-title":"Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells","volume":"19","author":"Frazier","year":"1996","journal-title":"Int. J. Pancreatol."},{"key":"10.1016\/j.jbior.2018.06.002_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jbior.2017.10.004","article-title":"Therapeutic application of apoptosis signal-regulating kinase 1 inhibitors","volume":"66","author":"Fujisawa","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jbior.2017.10.005","article-title":"Sphingosine kinase 1 in breast cancer","volume":"67","author":"Geffken","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jbior.2017.06.001","article-title":"Casein kinase II (CK2), glycogen synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia","volume":"65","author":"Gowda","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jbior.2016.09.003","article-title":"Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase (CK2) and Ikaros","volume":"63","author":"Gowda","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jbior.2017.08.003","article-title":"ASK1 in neurodegeneration","volume":"66","author":"Guo","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib46","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cdd.2013.17","article-title":"Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis","volume":"20","author":"Hanel","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbior.2018.06.002_bib47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jbior.2017.06.003","article-title":"GSK3 and its interactions with the PI3K\/AKT\/mTOR signalling network","volume":"65","author":"Hermida","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00423-007-0266-2","article-title":"Tobacco and the risk of pancreatic cancer: a review and meta-analysis","volume":"393","author":"Iodice","year":"2008","journal-title":"Langenbeck's Arch. Surg."},{"key":"10.1016\/j.jbior.2018.06.002_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jbior.2017.11.003","article-title":"PLC\u03b31: potential arbitrator of cancer progression","volume":"67","author":"Jang","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib50","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1046\/j.1523-1747.1998.00352.x","article-title":"Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells","volume":"111","author":"Jee","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jbior.2018.06.002_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jbior.2016.12.001","article-title":"Discrete signaling mechanisms of mTORC1 and mTORC2: connected yet apart in cellular and molecular aspects","volume":"64","author":"Jhanwar-Uniyal","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib52","first-page":"1305","article-title":"Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts","volume":"21","author":"Jiao","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jbior.2018.06.002_bib53","doi-asserted-by":"crossref","first-page":"62533","DOI":"10.18632\/oncotarget.11530","article-title":"Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature","volume":"7","author":"Jung","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2018.06.002_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mc.20453","article-title":"p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo","volume":"48","author":"Katiyar","year":"2009","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.jbior.2018.06.002_bib55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mc.20855","article-title":"Genetic susceptibility to pancreatic cancer","volume":"51","author":"Klein","year":"2012","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.jbior.2018.06.002_bib56","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nrc3420","article-title":"Identifying people at a high risk of developing pancreatic cancer","volume":"13","author":"Klein","year":"2013","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.jbior.2018.06.002_bib57","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1101\/gad.10.9.1054","article-title":"p53: puzzle and paradigm","volume":"10","author":"Ko","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.jbior.2018.06.002_bib58","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.3390\/cancers10010024","article-title":"Contemporary management of localized resectable pancreatic cancer","volume":"10","author":"Kommalapati","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jbior.2018.06.002_bib59","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejca.2015.12.002","article-title":"p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E\/K) BRAF melanoma to vemurafenib","volume":"55","author":"Krayem","year":"2016","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.jbior.2018.06.002_bib60","doi-asserted-by":"crossref","first-page":"7170","DOI":"10.1128\/MCB.25.16.7170-7180.2005","article-title":"Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance","volume":"25","author":"Kulikov","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbior.2018.06.002_bib61","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1200\/JCO.2015.62.8719","article-title":"Randomized phase Ib\/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer","volume":"33","author":"Kumar","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbior.2018.06.002_bib62","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ccr.2009.03.003","article-title":"PRIMA-1 reactivates mutant p53 by covalent binding to the core domain","volume":"15","author":"Lambert","year":"2009","journal-title":"Canc. Cell"},{"key":"10.1016\/j.jbior.2018.06.002_bib63","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1158\/0008-5472.CAN-04-1612","article-title":"Phosphatidylinositol 3'-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in advanced prostate cancer cells","volume":"64","author":"Lee","year":"2004","journal-title":"Canc. Res."},{"key":"10.1016\/j.jbior.2018.06.002_bib64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4161\/cc.6.5.3901","article-title":"A dominant role for p53-dependent cellular senescence in radiosensitization of human prostate cancer cells","volume":"6","author":"Lehmann","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbior.2018.06.002_bib65","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1200\/JCO.2011.40.7783","article-title":"Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer","volume":"30","author":"Lehmann","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbior.2018.06.002_bib66","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jbior.2017.10.006","article-title":"Signaling by cell surface death receptors: alterations in head and neck cancer","volume":"67","author":"Leonard","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib67","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/onc.2009.376","article-title":"A common gain of function of p53 cancer mutants in inducing genetic instability","volume":"29","author":"Liu","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2018.06.002_bib68","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1159\/000354520","article-title":"Berberine induces apoptosis in p53-null leukemia cells by down-regulating XIAP at the post-transcriptional level","volume":"32","author":"Liu","year":"2013","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.jbior.2018.06.002_bib69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jbior.2017.10.011","article-title":"ASK family in cardiovascular biology and medicine","volume":"66","author":"Liu","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib70","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/annonc\/mdr120","article-title":"Alcohol consumption and pancreatic cancer: a pooled analysis in the international pancreatic cancer case-control consortium (PanC4)","volume":"23","author":"Lucenteforte","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jbior.2018.06.002_bib71","doi-asserted-by":"crossref","first-page":"E41102","DOI":"10.1371\/journal.pone.0041102","article-title":"Glycogen synthase kinase-3 inhibition sensitizes pancreatic cancer cells to TRAIL-induced apoptosis","volume":"7","author":"Mamaghani","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbior.2018.06.002_bib72","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/carcin\/bgr309","article-title":"Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms","volume":"33","author":"Marchand","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jbior.2018.06.002_bib73","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1074\/jbc.M114.616714","article-title":"Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells","volume":"290","author":"Marchand","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbior.2018.06.002_bib74","first-page":"323","article-title":"Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4","volume":"21","author":"Masetti","year":"2018","journal-title":"Canc. Biomark"},{"key":"10.1016\/j.jbior.2018.06.002_bib75","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jbior.2017.10.007","article-title":"Physiological roles of ASK family members in innate immunity and their involvement in pathogenesis of immune diseases","volume":"66","author":"Matsuzawa","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib76","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2008.207","article-title":"Involvement of p53 and Raf\/MEK\/ERK pathways in hematopoietic drug resistance","volume":"22","author":"McCubrey","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2018.06.002_bib77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jbior.2014.09.016","article-title":"Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis","volume":"57","author":"McCubrey","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib78","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.18632\/aging.101250","article-title":"Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs","volume":"9","author":"McCubrey","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jbior.2018.06.002_bib79","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jbior.2017.05.005","article-title":"Regulation of GSK-3 activity by curcumin, berberine and resveratrol: potential effects on multiple diseases","volume":"65","author":"McCubrey","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib80","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jbior.2016.10.001","article-title":"Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis","volume":"63","author":"McCubrey","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib81","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jbior.2017.09.012","article-title":"Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals","volume":"67","author":"McCubrey","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2017.06.004","article-title":"GSK-3 signaling in health","volume":"65","author":"McCubrey","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib83","first-page":"1213","article-title":"Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan)","volume":"21","author":"Michaud","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jbior.2018.06.002_bib84","first-page":"980","article-title":"Improved retroviral vectors for gene transfer and expression","volume":"7","author":"Miller","year":"1989","journal-title":"Biotechniques"},{"key":"10.1016\/j.jbior.2018.06.002_bib85","doi-asserted-by":"crossref","first-page":"E1794","DOI":"10.1038\/cddis.2015.143","article-title":"APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells","volume":"6","author":"Mohell","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbior.2018.06.002_bib86","first-page":"825","article-title":"Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells","volume":"22","author":"Mohiuddin","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jbior.2018.06.002_bib87","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/j.gastro.2010.03.034","article-title":"Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma","volume":"139","author":"Morton","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbior.2018.06.002_bib88","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.0908428107","article-title":"Mutant p53 drives metastasis and overcomes growth arrest\/senescence in pancreatic cancer","volume":"107","author":"Morton","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jbior.2018.06.002_bib89","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.disamonth.2013.08.001","article-title":"Pancreatic cancer: a comprehensive review and update","volume":"59","author":"Muniraj","year":"2013","journal-title":"Disease-a-Month"},{"key":"10.1016\/j.jbior.2018.06.002_bib90","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2478\/s11658-012-0039-y","article-title":"Pharmacological inhibition of GSK3 attenuates DNA damage-induced apoptosis via reduction of p53 mitochondrial translocation and Bax oligomerization in neuroblastoma SH-SY5Y cells","volume":"18","author":"Ngok-Ngam","year":"2013","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.jbior.2018.06.002_bib91","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jbior.2017.05.004","article-title":"The regulatory and signaling mechanisms of the ASK family","author":"Nishida","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10689-014-9755-y","article-title":"Familial and sporadic pancreatic cancer share the same molecular pathogenesis","volume":"14","author":"Norris","year":"2015","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.jbior.2018.06.002_bib93","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/humu.10081","article-title":"The IARC TP53 database: new online mutation analysis and recommendations to users","volume":"19","author":"Olivier","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jbior.2018.06.002_bib94","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jbior.2017.01.002","article-title":"Genomic instability and proliferation\/survival pathways in RB1-deficient malignancies","volume":"64","author":"Pappas","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib95","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fonc.2015.00288","article-title":"Targeting oncogenic mutant p53 for cancer therapy","volume":"5","author":"Parrales","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbior.2018.06.002_bib96","doi-asserted-by":"crossref","first-page":"41792","DOI":"10.18632\/oncotarget.18355","article-title":"Tumor diversity and evolution revealed through RADseq","volume":"8","author":"Perry","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2018.06.002_bib97","doi-asserted-by":"crossref","first-page":"12062","DOI":"10.3748\/wjg.v20.i34.12062","article-title":"Nuclear receptors and pathogenesis of pancreatic cancer","volume":"20","author":"Polvani","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jbior.2018.06.002_bib98","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jbior.2015.09.001","article-title":"Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation","volume":"60","author":"Pyne","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib99","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jbior.2017.09.006","article-title":"Sphingosine 1-phosphate and cancer","volume":"68","author":"Pyne","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib100","doi-asserted-by":"crossref","first-page":"26142","DOI":"10.1038\/srep26142","article-title":"A small molecule inhibitor of PDK1\/PLC\u03b31 interaction blocks breast and melanoma cancer cell invasion","volume":"6","author":"Raimondi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbior.2018.06.002_bib101","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jbior.2017.09.001","article-title":"Phosphoinositide 5-phophatase activities control cell motility in glioblastoma: two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved","volume":"67","author":"Ramos","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib102","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/jnci\/djp535","article-title":"Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma","volume":"102","author":"Rasheed","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jbior.2018.06.002_bib103","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jbior.2017.10.010","article-title":"PIM activity in tumours: a key node of therapy resistance","volume":"67","author":"Rebello","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib104","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jbior.2017.05.002","article-title":"Targeting the Akt, GSK-3, Bcl-2 axis in acute myeloid leukemia","volume":"65","author":"Ricciardi","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/2159-8290.CD-11-0194","article-title":"ATM mutations in patients with hereditary pancreatic cancer","volume":"2","author":"Roberts","year":"2012","journal-title":"Canc. Discov."},{"key":"10.1016\/j.jbior.2018.06.002_bib106","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","article-title":"Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer","volume":"6","author":"Roberts","year":"2016","journal-title":"Canc. Discov."},{"key":"10.1016\/j.jbior.2018.06.002_bib107","doi-asserted-by":"crossref","first-page":"6442","DOI":"10.1038\/onc.2010.382","article-title":"PRIMA-1(MET)\/APR-246 targets mutant forms of p53 family members p63 and p73","volume":"29","author":"Rokaeus","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2018.06.002_bib108","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jbior.2017.11.004","article-title":"Proliferative and metastatic roles for phospholipase D in mouse models of cancer","volume":"67","author":"Roth","year":"2018","journal-title":"Adv. Biol. Regul."},{"issue":"1","key":"10.1016\/j.jbior.2018.06.002_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10010016","article-title":"Locally advanced pancreatic cancer: a review of local ablative therapies","volume":"10","author":"Ruarus","year":"2018","journal-title":"Cancer (Basel)"},{"key":"10.1016\/j.jbior.2018.06.002_bib110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jbior.2017.10.003","article-title":"Regulation of ASK1 signaling by scaffold and adaptor proteins","volume":"66","author":"Rusnak","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jbior.2017.05.001","article-title":"GSK-3 as a novel prognostic indicator in leukemia","volume":"65","author":"Ruvolo","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbior.2017.03.002","article-title":"Cross-talk between the CK2 and AKT signaling pathways in cancer","volume":"64","author":"Ruzzene","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib113","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jbior.2017.05.003","article-title":"ASK family and cancer","volume":"66","author":"Ryuno","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib114","doi-asserted-by":"crossref","first-page":"e0189051","DOI":"10.1371\/journal.pone.0189051","article-title":"Reprogramming pancreatic stellate cells via p53 activation: a putative target for pancreatic cancer therapy","volume":"12","author":"Saison-Ridinger","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jbior.2018.06.002_bib115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jbior.2015.11.006","article-title":"Phospholipase C\u03b2 connects G protein signaling with RNA interference","volume":"61","author":"Scarlata","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib116","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jbior.2017.09.004","article-title":"Phospholipase C\u03b2 interacts with cytosolic partners to regulate cell proliferation","volume":"67","author":"Scarlata","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib117","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature17403","article-title":"The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression","volume":"532","author":"Seifert","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2018.06.002_bib118","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1073\/pnas.72.11.4435","article-title":"Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro","volume":"72","author":"Shin","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jbior.2018.06.002_bib119","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics","volume":"63","author":"Siegel","year":"2013","journal-title":"CACanc. J. Clin."},{"key":"10.1016\/j.jbior.2018.06.002_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12029-017-0021-z","article-title":"Clinical factors as a component of the personalized treatment approach to advanced pancreatic cancer: a systematic literature review","volume":"49","author":"Skelton","year":"2018","journal-title":"J. Gastrointest. Canc."},{"key":"10.1016\/j.jbior.2018.06.002_bib121","first-page":"3144","article-title":"Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature","volume":"125","author":"Solomon","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jbior.2018.06.002_bib122","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/ncb1571","article-title":"p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM","volume":"9","author":"Song","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbior.2018.06.002_bib123","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/bcp.12958","article-title":"The therapeutic potential of mTOR inhibitors in breast cancer","volume":"82","author":"Steelman","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jbior.2018.06.002_bib124","doi-asserted-by":"crossref","first-page":"113013","DOI":"10.18632\/oncotarget.22956","article-title":"Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression","volume":"8","author":"Steelman","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2018.06.002_bib125","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.4161\/cc.10.17.17119","article-title":"Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells","volume":"10","author":"Steelman","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbior.2018.06.002_bib126","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1038\/onc.2008.49","article-title":"Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors","volume":"27","author":"Steelman","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jbior.2018.06.002_bib127","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jbior.2015.09.009","article-title":"Reciprocal regulation of p53 and NF-\u03baB by diacylglycerol kinase \u03b6","volume":"60","author":"Tanaka","year":"2016","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib128","first-page":"70","article-title":"Treatment of metastatic pancreatic adenocarcinoma: a review","volume":"28","author":"Thota","year":"2014","journal-title":"Oncology (Williston Park, NY)"},{"key":"10.1016\/j.jbior.2018.06.002_bib129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jbior.2017.10.009","article-title":"Review of four major distinct types of human phospholipase A2","volume":"67","author":"Vasquez","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib130","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1200\/JCO.2011.36.5742","article-title":"Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I\/II trial","volume":"29","author":"Von Hoff","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbior.2018.06.002_bib131","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.bbagrm.2014.05.027","article-title":"Berberine-induced tumor suppressor p53 up-regulation gets involved in the regulatory network of MIR-23a in hepatocellular carcinoma","volume":"1839","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbior.2018.06.002_bib132","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mrfmmm.2012.04.005","article-title":"Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells","volume":"734","author":"Wang","year":"2012","journal-title":"Mutat. Res."},{"key":"10.1016\/j.jbior.2018.06.002_bib133","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/mc.20571","article-title":"Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling","volume":"49","author":"Watson","year":"2010","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.jbior.2018.06.002_bib134","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cell.2014.01.066","article-title":"Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor \u03b2 signaling","volume":"157","author":"Weissmueller","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jbior.2018.06.002_bib135","first-page":"635","article-title":"The proteasome inhibitor MG132 induces apoptosis in human pancreatic cancer cells","volume":"14","author":"Wente","year":"2005","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jbior.2018.06.002_bib136","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ng.3052","article-title":"Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer","volume":"46","author":"Wolpin","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbior.2018.06.002_bib137","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2016.03.010","article-title":"Loss of P53 function activates JAK2-STAT3 signaling to promote pancreatic tumor growth, stroma modification, and gemcitabine resistance in mice and Is associated with patient survival","volume":"151","author":"W\u00f6rmann","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbior.2018.06.002_bib138","doi-asserted-by":"crossref","first-page":"E1108","DOI":"10.1038\/cddis.2014.75","article-title":"Unequal prognostic potentials of p53 gain-of-function mutations in human cancers associate with drug-metabolizing activity","volume":"5","author":"Xu","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jbior.2018.06.002_bib139","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jbior.2016.10.004","article-title":"Machineries regulating the activity of the small GTPase Arf6 in cancer cells are potential targets for developing innovative anti-cancer drugs","volume":"63","author":"Yamauchi","year":"2017","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2018.06.002_bib140","doi-asserted-by":"crossref","first-page":"14229","DOI":"10.1074\/jbc.M109.097253","article-title":"Characterization of functional domains necessary for mutant p53 gain of function","volume":"285","author":"Yan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbior.2018.06.002_bib141","doi-asserted-by":"crossref","first-page":"13249","DOI":"10.1038\/srep13249","article-title":"Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells","volume":"5","author":"Yoshino","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbior.2018.06.002_bib142","first-page":"411","article-title":"PRIMA-1MET inhibits growth of mouse tumors carrying mutant p53","volume":"30","author":"Zache","year":"2008","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.jbior.2018.06.002_bib143","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1158\/1078-0432.CCR-10-3168","article-title":"PRIMA-1Met\/APR-246 induces apoptosis and tumor growth delay in small cell lung cancer expressing mutant p53","volume":"17","author":"Zandi","year":"2011","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.jbior.2018.06.002_bib144","doi-asserted-by":"crossref","first-page":"71105","DOI":"10.18632\/oncotarget.20537","article-title":"Identification of candidate genes related to pancreatic cancer based on analysis of gene co-expression and protein-protein interaction network","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbior.2018.06.002_bib145","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1158\/0008-5472.CAN-10-1546","article-title":"Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells","volume":"70","author":"Zhang","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.jbior.2018.06.002_bib146","doi-asserted-by":"crossref","first-page":"E196","DOI":"10.1038\/oncsis.2016.8","article-title":"Gain of function of mutant p53: R282W on the peak?","volume":"5","author":"Zhang","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jbior.2018.06.002_bib147","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13045-017-0551-7","article-title":"Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions","volume":"11","author":"Zhang","year":"2016","journal-title":"J. Hematol. Oncol."}],"container-title":["Advances in Biological Regulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492618301131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492618301131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:55:00Z","timestamp":1762606500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212492618301131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":147,"alternative-id":["S2212492618301131"],"URL":"https:\/\/doi.org\/10.1016\/j.jbior.2018.06.002","relation":{},"ISSN":["2212-4926"],"issn-type":[{"value":"2212-4926","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals","name":"articletitle","label":"Article Title"},{"value":"Advances in Biological Regulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbior.2018.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}